Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Change in Cash (2020 - 2025)

Biofrontera has reported Change in Cash over the past 6 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Change in Cash at $3.0 million for Q4 2025, down 1.88% from a year ago — trailing twelve months through Dec 2025 was $487000.0 (down 89.32% YoY), and the annual figure for FY2025 was $487000.0, down 89.32%.
  • Change in Cash for Q4 2025 was $3.0 million at Biofrontera, up from -$3.8 million in the prior quarter.
  • Over the last five years, Change in Cash for BFRIW hit a ceiling of $22.8 million in Q4 2021 and a floor of -$10.4 million in Q4 2022.
  • Median Change in Cash over the past 5 years was -$1.5 million (2021), compared with a mean of -$84250.0.
  • Peak annual rise in Change in Cash hit 870.46% in 2025, while the deepest fall reached 266.53% in 2025.
  • Biofrontera's Change in Cash stood at $22.8 million in 2021, then tumbled by 145.37% to -$10.4 million in 2022, then skyrocketed by 79.93% to -$2.1 million in 2023, then soared by 245.84% to $3.0 million in 2024, then dropped by 1.88% to $3.0 million in 2025.
  • The last three reported values for Change in Cash were $3.0 million (Q4 2025), -$3.8 million (Q3 2025), and $5.5 million (Q2 2025) per Business Quant data.